COVID-19 Guidance for Summer 2021 Operations

Indiana University has released new COVID-19 safety guidance for summer 2021. Those who voluntarily report vaccinations to IU will be excluded from mitigation testing and will no longer need to quarantine if identified as a close contact with a positive case of COVID-19 and are asymptomatic. Masking is still required. While travel still involves some restrictions, vaccinated domestic travelers are not required to minimize activities, quarantine, or pursue testing upon return. Please visit the IU Restart Committee Recommendations for Summer 2021 for more information.

Federal Agency Guidance Concerning Existing Grants

  • Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19)
  • Per OMB:  OMB is allowing Federal agencies to grant class exceptions in instances where the agency has determined that the purpose of the Federal awards is to support the continued research and services necessary to carry out the emergency response related to COVID-19. Further, agencies are reminded of their existing flexibility to issue exceptions on a case-by-case basis in accordance with 2 CFR § 200.102, Exceptions. The Administration will evaluate if these flexibilities should be extended to recipients whose operations have been adversely impacted in the emergency response related to COVID-19 at a later date.

Research Compliance Guidance

The IU Research Compliance Office continues to be fully operational. Operations will continue without interruption even in the event of additional campus restrictions and/or closure. Many staff are already working remotely, and we are prepared to conduct IRB, IACUC, IBC, and COI meetings remotely.

Find answers to compliance questions on restarting research

Other Guidance for Research Universities

IU Internal Funding Guidance

Please see the Internal Funding Opportunities section of this website for the most current list of open funding programs. If you have questions about an internal grant program funded by VPR, OVPR, or OVCR, please contact the following:

VPR and OVPR internal grants:

OVCR internal grants: Alicia Gahimer,

Research Innovation, Commercialization, Technology Transfer

IU’s Innovation and Commercialization Office (ICO) is available to provide support for any new SBIR/STTR opportunities related to COVID-19. Also, ICO can provide support for specific sections of other federal grants (e.g. commercialization plans) that require input from our office. Please contact Amie Frame ( for assistance. Please provide the RFA number or a link to the RFA in your email as well as contact information for the lead PI and all other investigators involved in the research.

ICO looks forward to working with all faculty and staff to ensure the development of competitive grants for the $2.5B federal SBIR/STTR grants and contracts programs along with all other federal grants requiring Intellectual Property Management and Commercialization plans. The deadline for the SBIR/STTR grants that were to be submitted by the April round has been delayed to May 1, 2020.

Yes, Invention Disclosures will be accepted through IU's ICO Sophia database by Wellspring. There is currently no disruption to this process.

​Yes, although there may be some delays in negotiations.

You should always assume that a deadline previously described to you still applies. These deadlines are typically identified in correspondence from IU’s patent counsel describing the action that needs to be taken. Typically, governmental patent offices do not either close or extend deadlines, even for events that could cause broad disruptions in communication. However, the same situations that result in a reduction in ICO operations could possibly cause such closures or extensions. As a result, ICO and outside patent counsel continually monitor for patent office closures or changes in applicable deadlines. We will take such closures or extensions into account, but we will instruct our patent counsel to take action during this period to preserve all substantive rights possible.

Importantly, while there are sometimes ways for us to receive additional time to take action with respect to a pending application (e.g., under existing or emergency rules), we must assume this does not apply to the filing of new patent applications in advance of publications or new prior art. So, everyone involved should work with our patent counsel to secure timely filing of new applications during this period.


​If you have emailed and telephoned an ICO team member about an urgent issue, but have not received a response, please email